Full Press Release Details
AI Completes Exclusive License of Patents Covering Use of Blockchain-enabled Smart Contracts for Commercial Prescription Drug Distribution
Industry to Wellgistics Health PharmacyChain Health Data Railroad'
| Partnership positions Wellgistics Health to become the Web 3.0 Health Information Data Transfer Leader in the $634 billion Prescription Drug Industry 1 | ||
| Implementation of Wellgistics proprietary EinsteinRx artificial intelligence hub to facilitate automated prescription fulfillment optimization for manufacturers, pharmacies, physicians, patients and payers | ||
| DataVault's enabling intellectual property provides smart contracts barrier to entry in the $4.9 trillion US healthcare market 2 | ||
| PwC estimates $1 trillion opportunity to shift healthcare spending towards a digital-first, proactive and personalized system 3 of care that minimizes administrative burden |
FL, November 25, 2025 - DataVault AI, Inc. ("DataVault") (NASDAQ: DVLT) , leading the way in AI data experience,
valuation, and monetization, and Wellgistics Health, Inc. ("Wellgistics") (NASDAQ: WGRX), a health information
technology leader implementing EinsteinRx artificial intelligence prescription routing for the physical dispensing of precriptions
drugs with PharmacyChain blockchain-enabled smart contracts to optimize the tracking, dispending and insurance coverage of prescription
pharmaceutical drugs from manufacturer to dispensing from pharmacy to patient, today announced the companies have entered into an exclusive
license for Wellgistics to gain access to patents enabling exclusivity within the field pharmaceutical drug distribution. The objective
of PharmacyChain is to fully digitize the tracking of prescription drugs from script to fulfillment, inclusive of all electronic medical
records, diagnostic and health information needed to make healthcare decisions, in order to ensure the right drug gets to the right patient
at the right time, with the right recommendations for safe and effective use. Under the terms of the agreement, the license would survive
a chain of control of Wellgistics Health.
license agreement puts DataVault AI's proprietary intellectual property enables Wellgistics AI to significantly disrupt the $634
billion US prescription drug industry1," said Nathaniel Bradley, President & CEO of DataVault AI. "Web 3.0
smart contracts are the future of secure data transfer that allow for the automation of key functions to more quickly close loops that
leave tasks open that slow down the conduct of the business in the $4.9 trillion healthcare industry2. We see the potential
for significant improvement in the cost and efficiency of filling prescriptions that will reduce costs for payers while improving outcomes
for patients and giving better data to the manufacturer. PharmacyChain is a better way to achieve this for the various stakeholders
in the prescription drug and healthcare ecosystems."
the completion of Wellgistics Health's EnsteinRx' aritifical intelligence-enabled hub that integrates all of its information
technology infrastructure with its physical infrastructure that includes over 6500 independent pharmacies nationwide and its own in-house
pharmacy (physical/online), Wellgistics is poised to be able to use PharmacyChain smart contracts to close the loop that otherwise forces
manufacturers to pay significant rebates to pharmacy benefits managers (PBMs) associated with national insurance companies. By enabling
payers with greater visibility and transparency, Wellgistics expects to be able to attract employers, HMOs and other payers to fulfill
prescriptions drugs through its pharmacy network.
that we have completed EinsteinRd, we are poised to put it on the PharmacyChain blockhchain-enabled smart contract platform and
become the leading smart contract-enabled pharmaceutical distribution platform in the country," said Prashant Patel, RPh, President
& Interim-CEO of Wellgistics. "With defensible IP now backing our effort, we will accelerate our efforts to integrate EinsteinRx
into our customers' workflow and work through the various steps to ensure the creation of an optimal blockchain protocol that we
expect to become the standard in the commercial prescription drug distribution industry. By minimizing or eliminating PBM rebates for
pharmacies and manufacturers while reducing administrative burden for payers, Wellgistics intends to disrupt and improve the path through
which prescription drugs are dispensed in the United States. Given our CTO Srini Kalla's background at OptumRX, we intend to find
new ways to reduce out-of-pocket costs by empowering patients with the ability to monetize their data to manufacturers or other stakeholders
within the healthcare system."
AI (Nasdaq: DVLT) is leading the way in AI driven data experiences, valuation and monetization of assets in the Web 3.0 environment.
The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data
Science Divisions. Datavault AI's Acoustic Science Division features WiSA , ADIO and Sumerian patented technologies
and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization
and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing
to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI's cloud-based platform provides
comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues,
biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange (IDE) enables Digital Twins,
licensing of name, image and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering
responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML)
automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered
in Philadelphia, PA.
more about Datavault AI at www.dvlt.ai.
Wellgistics Health, Inc.
Health (NASDAQ:WGRX) is pharmacy physical and technology enabling health IT company that specializes in optimizing the delivery medications
from manufacturers to patients. Its integrated platform connects 6,500+ pharmacies and 200+ manufacturers, offering wholesale distribution,
digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior
authorization, and cash-pay fulfillment. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust
more information, visit www.wellgisticshealth.com.
press release contains forward-looking statements within the meaning of the federal securities laws, including, without limitation, statements
regarding the parties' plans to negotiate definitive agreements, potential implementation, adoption, performance, revenue sharing
and other anticipated benefits of the contemplated collaboration. These statements are subject to risks and uncertainties that could
cause actual results to differ materially, including those described in DataVault AI, Inc.'s and Wellgistics Health, Inc.'s
filings with the SEC. Forward-looking statements speak only as of the date hereof, and neither company undertakes any obligation to update
them except as required by law.Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.
press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction, and there
shall be no sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Investor Relations Contact
Corporate Communications Group, LLC
Avenue of the Americas, 5th Floor